Brainomix 360 e-CTA vs Viz CTP
AI Verdict
Choose Brainomix 360 e-CTA if…
Choose Brainomix 360 e-CTA if your primary need is highly accurate, automated assessment of collateral status and large vessel occlusion (LVO) detection on CT angiography scans for acute stroke patients. It excels in providing a standardized collateral score and multi-planar reconstructions, making it ideal for facilities focused on detailed CTA analysis and quality control of acquisition phases.
View Brainomix 360 e-CTA →Choose Viz CTP if…
Choose Viz CTP if your institution requires a comprehensive AI-powered platform for rapid disease detection and intelligent care coordination across a broader range of neurovascular conditions beyond just CTA analysis. Its strengths lie in leveraging over 50 FDA-cleared algorithms, real-time mobile access to high-fidelity imaging with 3D manipulation, and a HIPAA-compliant communication platform for streamlined workflow and faster treatment decisions.
View Viz CTP →When choosing between Brainomix 360 e-CTA and Viz CTP, physicians should consider their primary need: specialized stroke assessment versus a broader AI-powered care coordination platform. Brainomix 360 e-CTA excels in its focused approach to acute stroke, offering automated and standardized assessment of collaterals and large vessel occlusions (LVOs) on CT angiography (CTA) scans. Its key practical difference lies in its dedicated collateral assessment, providing a CTA Collateral Score (CTA-CS) and indicating CTA acquisition phase for quality control, which can be crucial for precise stroke intervention decisions. This tool is best suited for stroke centers or emergency departments prioritizing in-depth, automated CTA analysis for stroke patients.
Viz CTP, on the other hand, offers a more comprehensive solution with over 50 FDA-cleared algorithms for various disease detections, extending beyond just stroke. While it also provides LVO detection and automated image analysis, its core strength lies in intelligent care coordination, real-time mobile access to imaging, and HIPAA-compliant communication. The key practical difference here is its integrated care coordination platform, which streamlines workflows and facilitates communication among care teams. Viz CTP is ideal for institutions seeking a versatile AI platform that not only aids in diagnosis across multiple conditions but also enhances team communication and workflow efficiency, making it suitable for a broader range of specialties within a hospital system.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Brainomix 360 e-CTA | Viz CTP |
|---|---|---|
| Pricing | Contact vendor | Subscription model |
| Deployment | Cloud service (EU and US) and on-site server within the hospital network. | Cloud-native solution, integrates with PACS and EHRs. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz CTPViz CTP emphasizes real-time, mobile access to high-fidelity imaging and a HIPAA-compliant communication platform, suggesting a strong focus on intuitive user experience and care coordination. Brainomix 360 e-CTA also offers mobile access and email notifications, but Viz.ai's broader suite of 50+ FDA-cleared algorithms and focus on intelligent care coordination implies a more comprehensive and integrated user workflow.
Clinical Value
Viz CTPViz CTP boasts over 50 FDA-cleared algorithms for disease detection and intelligent care coordination, indicating a wider range of clinical applications and validated capabilities. While Brainomix 360 e-CTA is FDA-cleared and has strong clinical validation for stroke assessment, Viz.ai's extensive portfolio suggests broader clinical utility across various neurological pathologies and beyond.
Pricing & Value
TieBoth tools require contacting the vendor for specific pricing, making a direct comparison of value difficult. Brainomix offers individual module licensing or package deals, while Viz.ai uses a subscription model based on algorithms and population size. Without transparent pricing, it's impossible to determine which offers better value.
Enterprise Readiness
Viz CTPViz.ai highlights its cloud-native solution with integration into PACS and EHRs, along with HIPAA compliance and a Business Associate Agreement (BAA). Brainomix also offers cloud and on-site deployment, DICOM results to PACS, and implied HIPAA compliance, but Viz.ai's explicit mention of a BAA and broader integration capabilities suggest a more robust enterprise-ready solution.
Innovation
Viz CTPViz.ai positions itself as a pioneer in AI-powered disease detection and intelligent care coordination, with over 50 FDA-cleared algorithms and features like AI-powered motion artifact correction. Brainomix 360 e-CTA focuses on automated collateral assessment and LVO detection, which are innovative, but Viz.ai's broader algorithmic portfolio and emphasis on intelligent care coordination suggest a wider scope of innovation.
Support & Docs
TieBoth companies provide support resources. Brainomix offers user manuals, FAQs, and direct contact options. Viz.ai also provides customer resources, user guides, and a 'Viz Academy'. Without specific details on the depth, responsiveness, or accessibility of these resources, it's difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Brainomix 360 e-CTA | Viz CTP |
|---|---|---|
| Name | Brainomix 360 e-CTA | Viz CTP |
| Company | Brainomix Limited | Viz.ai |
| Description | Brainomix 360 e-CTA is an AI-powered module within the Brainomix 360 Stroke platform that automates and standardizes the assessment of collaterals and detects large vessel occlusions on CT angiography scans for acute stroke patients. | Viz.ai is a pioneer in AI-powered disease detection and intelligent care coordination, leveraging over 50 FDA-cleared algorithms to analyze medical imaging and streamline clinical workflows for faster diagnosis and treatment. |
| Key Features | Automated collateral assessment on CTA scans, Computation of CTA Collateral Score (CTA-CS), Automatic Large Vessel Occlusion (LVO) detection, Indication of CTA acquisition phase for quality control, Multi-planar reconstructions (MPRs) with coronal, sagittal, and axial viewing, Integration within Brainomix 360 Stroke platform, DICOM results sent automatically to PACS or other radiology systems, Email result notifications | AI-powered disease detection (50+ FDA-cleared algorithms), Real-time, mobile access to high-fidelity imaging (DICOM viewer, 3D manipulation), Intelligent care coordination and communication platform (HIPAA-compliant messaging), Automated image analysis and interpretation (e.g., CT perfusion maps, LVO detection), Prioritized worklists, EHR integration, AI-powered motion artifact correction for CTP, Automated measurements (e.g., ICH volume, subdural thickness/midline shift) |
| Specialties | Emergency Medicine, Neurology, Radiology | Emergency Medicine, Neurology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Brainomix 360 e-CTA and Viz CTP.
Frequently Asked Questions
More Comparisons
More matchups featuring Brainomix 360 e-CTA or Viz CTP
Backers
Who funded each tool's parent company.